{
    "2021-07-29": [
        [
            {
                "time": "2021-04-26",
                "original_text": "UPDATE 4-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant",
                "features": {
                    "keywords": [
                        "Emergent",
                        "J&J",
                        "COVID-19",
                        "vaccine",
                        "production",
                        "Baltimore"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "We must move towards vaccine mandates to get ahead of Covid-19: Doctor",
                "features": {
                    "keywords": [
                        "vaccine",
                        "mandates",
                        "Covid-19",
                        "Doctor"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Smart stock investors know to check this telling sign of a company’s health",
                "features": {
                    "keywords": [
                        "smart",
                        "investors",
                        "company’s health"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney",
                "features": {
                    "keywords": [
                        "Women",
                        "Cancer",
                        "Victims",
                        "Johnson & Johnson",
                        "Texas Two-Step",
                        "Bankruptcy",
                        "Reforms"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Sandy Hook families offered $33 million, J&J vaccine production to resume in Baltimore, AstraZeneca loses money on vaccine",
                "features": {
                    "keywords": [
                        "Sandy Hook",
                        "families",
                        "$33 million",
                        "J&J",
                        "vaccine",
                        "production",
                        "Baltimore",
                        "AstraZeneca",
                        "loses money"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant",
                "features": {
                    "keywords": [
                        "Emergent",
                        "BioSolutions",
                        "Stock",
                        "Higher",
                        "COVID-19",
                        "Vaccine",
                        "Production",
                        "Baltimore"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Are Johnson & Johnson's Legal Troubles Enough of a Reason to Avoid the Stock?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Legal",
                        "Troubles",
                        "Avoid",
                        "Stock"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "3 Dividend Stocks Safe Enough to Bet the Farm On",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Stocks",
                        "Safe",
                        "Bet",
                        "Farm"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Wall Street Might Be Missing This Key to Growth at Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "Missing",
                        "Key",
                        "Growth",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-26",
                "original_text": "Pfizer CEO on South Africa vaccine deal: 'They want to see production happening'",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "South Africa",
                        "vaccine",
                        "deal",
                        "production"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "international relations"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}